Patents
Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
10/2005
10/06/2005CA2599543A1 Oral health care drink and method for reducing malodors
10/06/2005CA2599345A1 Antimicrobial composition for pre-harvest and post-harvest treatment of plants and animals
10/06/2005CA2558346A1 Combination therapy
10/06/2005CA2557959A1 Stabilized peroxide compositions
10/06/2005CA2556459A1 Extended cycle multiphasic oral contraceptive method
10/06/2005CA2554860A1 Pharmaceutical composition and method for the transdermal delivery of magnesium
10/05/2005EP1582210A2 Compositions and methods for treating or preventing surgical adhesions
10/05/2005EP1581211A1 Contact lens and eye drop rewetter compositions and their uses
10/05/2005EP1581200A2 Compositions and methods for nutrition supplementation
10/05/2005EP1581184A1 Veterinary compositions for treating mastitis
10/05/2005EP1083887B1 Pharmaceutical compositions for the treatment of ulcers
10/05/2005CN1678524A Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate
10/05/2005CN1678328A Physiologically balanced, ionized, acidic solution and methodology for use in wound healing
10/05/2005CN1676135A Use of native silver for preparing antibacterial anti-inflammation, and element medicine and antiseptic
10/05/2005CN1221274C Medicine with acupuncture and moxibustion effect of stimulating main collateral channels and acupuncture point and its preparation method
10/05/2005CN1221268C Magnesium-calcium ion composite preparation and production process thereof
10/04/2005US6951890 Preventing and/or treating cardiovascular disease and/or associated heart failure
10/04/2005US6951642 Water-in-oil emulsions with anionic groups, compositions, and methods
09/2005
09/29/2005WO2005089803A2 Pharmaceutical compositions for the treatment of skin diseases comprising a combination of epinastine and one or more additional minerals or one or more crude drugs
09/29/2005WO2005089780A1 Composition against aids virus and method of selectively inactivating virus-infected cells
09/29/2005WO2005089779A2 Rapidly disintegrating taste-masked tablet
09/29/2005WO2005089740A1 Coenzyme q composition with long-term persistence in blood
09/29/2005WO2005089737A2 Materials and methods for inhibiting wip1
09/29/2005WO2005089715A1 Ophthalmic solution comprising sodium carboxymethylcellulose and hydroxypropylmethylcellulose
09/29/2005WO2005089448A2 Administration of cisplatin by inhalation
09/29/2005WO2005089426A2 Method of treating sepsis
09/29/2005WO2005089100A2 Decontamination formulations for disinfection and sterilization
09/29/2005WO2005065669A8 Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision
09/29/2005WO2005041925A3 Compositions and dosage forms for enhanced absorption
09/29/2005US20050215633 Use of neurotoxic substances for the production of a means for the treatment of joint paint and method for application of said means
09/29/2005US20050214388 Multivitamin formulations containing controlled-release magnesium
09/29/2005US20050214387 Low-dose potassium supplementation for the prevention and treatment of hypertension
09/29/2005US20050214386 Methods for deactivating allergens and preventing disease
09/29/2005US20050214385 Chromium/biotin treatment of dyslipidemia and diet-induced post prandial hyperglycemia
09/29/2005US20050214384 Chromium compositions and methods for using the same for inhibiting drug-induced insulin resistance
09/29/2005US20050214380 Nanobioprocessor for protein and cell therapy
09/29/2005US20050214262 Population of hematopoietic cells, made to exhibit a greater clonogenic potential, engraftment potential, immune system reconstitution potential and/or proportion of CD34+ positive cells by culturing with a transition metal compound that chelates copper such as tetraethylenepentamine
09/29/2005US20050214244 Menopause homeopathic formulations
09/29/2005US20050214243 Feminine homeopathic formulations
09/29/2005DE102004012009A1 Antidandruff compositions, e.g. shampoos, containing synergistic active agent combination of acetylsalicylic acid, zinc pyrithione and piroctone olamine
09/29/2005CA2560059A1 Platinum carboxylate anticancer compounds
09/29/2005CA2559722A1 Administration of cisplatin by inhalation
09/29/2005CA2557795A1 Ophthalmic solution comprising sodium carboxymethylcellulose and hydroxypropylmethylcellulose
09/29/2005CA2555363A1 Coenzyme q compositions persisting in blood
09/28/2005EP1578349A2 Novel anti-bacterial compositions
09/28/2005EP1274458B1 Compositions containing a naphthalmide and an antiproliferative agent
09/28/2005EP1085804A4 Method and composition for the treatment of epidermal irritations and infections
09/28/2005CN1674942A Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
09/28/2005CN1674922A Methods of treating angiogenesis, tumor growth, and metastasis
09/28/2005CN1674908A Therapeutic combinations of erb B kinase inhibitors and antineoplastic therapies
09/28/2005CN1672689A Nano silver antiseptic gel for treating women's genital tract infection and its prepn and application
09/28/2005CN1220513C Chinese patent medicine for stopping blood, analgesia, removing blood stasis and engender new and its preparation method
09/28/2005CN1220508C Medicine for curing diseases of digestive system and its preparation method
09/28/2005CN1220499C Kidney-invigorating and Yang-strengthening wine
09/28/2005CN1220498C Medicament for treating asthma
09/27/2005US6949261 An isolate from the leaves of Gymnema sylvestre obtained by extracting Gymnema sylvestre leaves with aqueous ethanol, removing acid-insoluble salt from the extract, concentrating desalted extract, isolating an insulinotropically active principle
09/27/2005US6949260 Administering Boswellia gum extract comprising at least 10% by weight of boswellic acids, and turmeric gum extract comprising at least about 30% by weight of curcuminoids.
09/27/2005US6949249 Mixture contains flow control agent and thickener
09/27/2005US6949218 Use of low molecular weight amino alcohols in ophthalmic compositions
09/27/2005US6949133 Portable oxygen concentrator
09/27/2005CA2108104C Fibrin sealant compositions and methods for utilizing same
09/22/2005WO2005087288A1 Medicinal preparation for angiogenesis
09/22/2005WO2005087271A1 Compositions comprising cells and magnetic materials for targeted delivery
09/22/2005WO2005087216A2 Treatment of anaemic conditions by inhibition of erythrocyte apoptosis
09/22/2005WO2005087024A2 Product containing a highly bioavailable mineral, method for preparing and using
09/22/2005WO2005086971A2 Anti-metastatic ability of mibefradil and gadolinium
09/22/2005WO2005086814A2 Methods and compositions related to regulation of cytokine production by glycogen synthase kinase 3 (gsk-3)
09/22/2005WO2005086697A2 Materials for medical implants and occlusive devices
09/22/2005WO2005086694A2 Occlusive biomedical devices, punctum plugs, and methods of use thereof
09/22/2005WO2005074947A3 Anti-viral pharmaceutical compositions
09/22/2005US20050209310 Methods for modulating tumor growth and metastasis
09/22/2005US20050209177 Combined use of genes that block oncogenic cell signalling pathways and chemotherapeutic and or radiotherapeutic agents
09/22/2005US20050208154 Antidepressants for treating manic disorders, psychosis; comprising ethyl cellulose, talc, polyvinylpyrrolidone; time-release dosage form; once daily
09/22/2005US20050208152 Pharmaceutical compositions primarily for the treatment and prevention of genitourinary infections and their extragenital complications
09/22/2005US20050208151 Treatment of rheumatoid arthritis with FLIP antagonists
09/22/2005US20050208150 Compositions for elastrogenesis and connective tissue treatment
09/22/2005US20050208149 Use of arsenic-containing pharmaceutical composition in combination with radiation therapy for cancer treatment
09/22/2005US20050208148 Method of reducing risk of infection of a bovine teat after cessation of milking
09/22/2005US20050208137 comprising angiogenesis inhibitor retinoic acid, taxol and polymeric carrier polylactone; treating cancer, angiogenic-dependent diseases, embolizing blood vessels, and eliminating biliary, urethral, esophageal, tracheal/bronchial obstructions, corneal neovascularization; coated stents with the mixture
09/22/2005US20050208136 Antitumor agent and process for producing the same
09/22/2005US20050208121 Polymeric cannulae proteins, nucleic acids encoding them and methods for making and using them
09/22/2005US20050208094 Bone cement compositions having fiber-reinforcement and/or increased flowability
09/22/2005US20050208035 Nutritional composition for treating an immune condition
09/22/2005CA2560176A1 Occlusive biomedical devices, punctum plugs, and methods of use thereof
09/21/2005EP1576956A2 Chromium/biotin treatment of type II diabetes
09/21/2005EP1575552A2 Metal-containing materials, compositions and methods
09/21/2005EP1575549A2 Identification of anti-hiv compounds inhibiting virus assembly and binding of nucleocapsid protein to nucleic acid
09/21/2005EP1575359A1 Reduction of reactive oxygen species in chronic wound management
09/21/2005EP1438038A4 Method and composition for preventing or reducing the symptoms of insulin resistance syndrome
09/21/2005EP1435965A4 Pharmaceutical compositions and methods for treating cancer
09/21/2005CN1671405A Antipyrotic and method of manufacturing the same
09/21/2005CN1669560A Application of ferriferrous oxide particle in preparation of tumour heating treatment auxiliary drug
09/21/2005CN1669559A Medicine for treating rhinitis
09/21/2005CN1219537C Chinese medicine for treating leucocythemia and its preparation method
09/21/2005CN1219536C Lithiasis treating Chinese medicine preparation
09/21/2005CN1219526C Chinese medicine for bone-setting and method for preparing same
09/21/2005CN1219519C Exterior used preparation for treating skin trauma
09/20/2005US6946484 Controlling cancer by reducing its growth and improving response to therapy
09/20/2005US6946155 Preventing bulbs or seeds of vegetables, flowers from premature sprouting and rooting, by spraying a hydrogen peroxide solution containing silver, copper and zinc metallic ions, fogging with the microdroplet; food treatment
09/20/2005US6946151 Therapeutic compositions